Phi Pharma SA is developing a new class of anti-cancer drugs: peptide drug conjugates effective in multiple human cancers using an innovative mechanism of cell entry: novel sugar-based drug targets.

Location

Place du Midi 36, 1950 Sion, Switzerland

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2012

  • Number of employees in Switzerland

    1-9

Key business